|
1
|
Liu G, Zhang Y, Fu K, Hu J, Zhao Z, Fu W
and Liu G: Meta-analysis of the effect of preoperative chemotherapy
on Wilms' tumor. J BUON. 23:211–217. 2018.PubMed/NCBI
|
|
2
|
Davidoff AM: Wilms' tumor. Curr Opin
Pediatr. 21:357–364. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu CL, Wang WH, Sun YL, Zhuang HW, Xu M,
Chen HF and Liu JX: miR-144-3p inhibits the proliferation and
metastasis of pediatric Wilms' tumor cells by regulating Girdin.
Eur Rev Med Pharmacol Sci. 22:7671–7678. 2018.PubMed/NCBI
|
|
4
|
Grundy PE, Breslow NE, Li S, Perlman E,
Beckwith JB, Ritchey ML, Shamberger RC, Haase GM, D'Angio GJ,
Donaldson M, et al National Wilms Tumor Study Group, : Loss of
heterozygosity for chromosomes 1p and 16q is an adverse prognostic
factor in favorable-histology Wilms tumor: A report from the
National Wilms Tumor Study Group. J Clin Oncol. 23:7312–7321. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rivera MN and Haber DA: Wilms' tumour:
Connecting tumorigenesis and organ development in the kidney. Nat
Rev Cancer. 5:699–712. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gammell P: MicroRNAs: recently discovered
key regulators of proliferation and apoptosis in animal cells:
Identification of miRNAs regulating growth and survival.
Cytotechnology. 53:55–63. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ludwig N, Werner TV, Backes C, Trampert P,
Gessler M, Keller A, Lenhof HP, Graf N and Meese E: Combining miRNA
and mRNA expression profiles in Wilms tumor subtypes. Int J Mol
Sci. 17:4752016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jiang X and Li H: miR-1180-5p regulates
apoptosis of Wilms' tumor by targeting p73. OncoTargets Ther.
11:823–831. 2018. View Article : Google Scholar
|
|
9
|
Liu GL, Yang HJ, Liu B and Liu T: Effects
of microRNA-19b on the proliferation, apoptosis, and migration of
Wilms' tumor cells via the PTEN/PI3K/AKT signaling pathway. J Cell
Biochem. 118:3424–3434. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Krichevsky AM and Gabriely G: miR-21: A
small multi-faceted RNA. J Cell Mol Med. 13:39–53. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Asangani IA, Rasheed SA, Nikolova DA,
Leupold JH, Colburn NH, Post S and Allgayer H: MicroRNA-21 (miR-21)
post-transcriptionally downregulates tumor suppressor Pdcd4 and
stimulates invasion, intravasation and metastasis in colorectal
cancer. Oncogene. 27:2128–2136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gratias EJ, Jennings LJ, Anderson JR, Dome
JS, Grundy P and Perlman EJ: Gain of 1q is associated with inferior
event-free and overall survival in patients with favorable
histology Wilms tumor: A report from the Children's Oncology Group.
Cancer. 119:3887–3894. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Selcuklu SD, Donoghue MT and Spillane C:
miR-21 as a key regulator of oncogenic processes. Biochem Soc
Trans. 37:918–925. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Deng S, Calin GA, Croce CM, Coukos G and
Zhang L: Mechanisms of microRNA deregulation in human cancer. Cell
Cycle. 7:2643–2646. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ren Y, Zhou X, Mei M, Yuan XB, Han L, Wang
GX, Jia ZF, Xu P, Pu PY and Kang CS: MicroRNA-21 inhibitor
sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229
(PTEN-wild type) to taxol. BMC Cancer. 10:272010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Roldo C, Missiaglia E, Hagan JP, Falconi
M, Capelli P, Bersani S, Calin GA, Volinia S, Liu CG, Scarpa A, et
al: MicroRNA expression abnormalities in pancreatic endocrine and
acinar tumors are associated with distinctive pathologic features
and clinical behavior. J Clin Oncol. 24:4677–4684. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rossi L, Bonmassar E and Faraoni I:
Modification of miR gene expression pattern in human colon cancer
cells following exposure to 5-fluorouracil in vitro. Pharmacol Res.
56:248–253. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lawrie CH: MicroRNAs and haematology:
Small molecules, big function. Br J Haematol. 137:503–512. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Panigrahi AR, Pinder SE, Chan SY, Paish
EC, Robertson JF and Ellis IO: The role of PTEN and its signalling
pathways, including AKT, in breast cancer; an assessment of
relationships with other prognostic factors and with outcome. J
Pathol. 204:93–100. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mocanu MM and Yellon DM: PTEN, the
Achilles' heel of myocardial ischaemia/reperfusion injury? Br J
Pharmacol. 150:833–838. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gregorian C, Nakashima J, Le Belle J, Ohab
J, Kim R, Liu A, Smith KB, Groszer M, Garcia AD, Sofroniew MV, et
al: Pten deletion in adult neural stem/progenitor cells enhances
constitutive neurogenesis. J Neurosci. 29:1874–1886. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu YR, Qi HJ, Deng DF, Luo YY and Yang SL:
MicroRNA-21 promotes cell proliferation, migration, and resistance
to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal
cancer. Tumour Biol. 37:12061–12070. 2016. View Article : Google Scholar : PubMed/NCBI
|
